Articles by Tim Burroughs
Deal focus: HaloDoc targets healthcare access
A spin-out from domestic pharmaceutical players Mensa Group, Indonesian healthcare services app HaloDoc wants to make medication and doctor consultations more accessible to the masses
VC value-add: Operational gambit
As competition for VC deals intensifies in Asia and capital becomes commoditized, GPs are stressing their value-add credentials. Should we believe the hype?
Sun Hung Kai appoints Sebastiaan van den Berg as CIO
Sebastiaan van den Berg, previously a managing director at HarbourVest Partners, has become CIO and head of principal investments at Hong Kong-based Sun Hung Kai & Co.
Australia VC: Interesting times
AirTree Ventures' successful fundraise underlines the growth interest in Australian venture capital, but the superannuation funds have yet to prove themselves to be a consistent source of capital
Indonesia healthcare services app gets $11m Series A
Clermont Group, a Singapore-based private investment firm led by billionaire Richard Chandler, has led a Series A round worth $11 million for Indonesian healthcare services app HaloDoc.
MBK shelves plan to exit Korea's Coway
MBK Partners has suspended plans to sell its holding in listed South Korean water purifier business Coway because the stock is thought to be undervalued.
Deal focus: Allegro to revamp Pizza Hut’s recipe
Allegro Funds plans new store expansion for Pizza Hut Australia, but first the GP and its management team partners will make operational improvements to the existing business
Riverside adds partner in Australia
The Riverside Company has promoted Nicholas Speer, a principal in its Melbourne office, to partner.
Foxconn invests $120m in China's Didi Chuxing
Foxconn Technology Group has invested $119.9 million in China-based ride-hailing platform Didi Chuxing at a valuation of $33.7 billion.
Korean LPs back Lindeman's $273m China fund
Lindeman Asia Investment, a South Korea and China-focused PE firm that concentrates on small and medium-sized enterprises, has launched a KRW300 billion ($273 million) fund with backing from domestic LPs.
Carlyle launches tender offer for Money Square Japan
The Carlyle Group has launched a tender offer for Money Square Japan, a Tokyo-listed provider of foreign exchange margin trading services.
PEP fully exits Australia-listed Link Group
Pacific Equity Partners (PEP) has completed its exit from Link Group, selling its stake in the Australian financial data and fund administration services provider alongside several other shareholders in a deal said to be worth A$872.3 million ($670 million).
Japan's Taiho Ventures backs US cancer drug developer
Taiho Ventures, the newly established VC arm of Japan’s Taiho Pharmaceutical, has participated in a $70 million Series B round of funding for Arcus Biosciences, a US-based start-up that develops cancer drugs.
Q&A: Aberdeen Asset Management's Andrew McCaffery
Andrew McCaffery, head of alternatives at Aberdeen Asset Management, discusses the long-term impact of investors becoming more aggressive in their pursuit of returns, almost regardless of the risk
Secondaries: Stick or twist?
After several years of rapid growth, secondaries volumes slowed in the first half of 2016, while fundraising reached an all-time high. Opinion is divided on the prospects for an increasingly nuanced market
LPs want GPs to show comprehensive approach to ESG - AVCJ Forum
Private equity firms need to incorporate environmental, social and governance (ESG) considerations into their investment strategies – and do so in a long term, end-to-end manner, LPs told the AVCJ ESG Forum.
PE exposure vital in weak global economy - Future Fund
Exposure to private equity and venture capital – where it is driven by true value creation rather than financial leverage or strong economic growth – has never been more important, according to Raphael Arndt, CIO of Australia’s Future Fund.
CLSA-backed BayCurrent lists in Tokyo
CLSA Capital Partners (CLSA CP) has made a partial exit from BayCurrent Consulting as the company raised JPY28.3 billion ($272 million) through an IPO on the Tokyo Stock Exchange.
Australia's Crescent exits Breezway to US trade buyer
Crescent Capital Partners sold Breezway, an Australian manufacturer of louvre windows for residential and commercial buildings, to US-based industry counterpart Jeld-Wen Holding.
Deal focus: Mr Vitamins gets deal-by-deal treatment
Executives from Ironbridge Capital and Catalyst Investment Managers team up with retail veteran Brett Blundy to take Australia's Mr Vitamins into its next stage of growth
NewQuest buys BPO asset from Ayala, Actis
Direct secondaries specialist NewQuest Capital Partners has acquired business process outsourcing (BPO) company Integreon from Philippines conglomerate Ayala Corporation and Actis Capital.
Korean LPs prioritize yield-generating alternatives - AVCJ Forum
Korean institutional investors are raising their allocations to alternative assets, but a need for yield means they favor assets like private debt and infrastructure over private equity.
Fund focus: Kerogen plays the long game
In the early stages of deployment of its $830 million second fund, Kerogen Capital faces a very different energy sector to the previous cycle, characterized by lower costs, lower entry prices and reduced competition
Side letters: A little extra
The proliferation of side letter provisions submitted by LPs as conditional on their participation in a fundraise is adding to administrative workloads. Private equity firms must negotiate carefully